Clinical Trials
8 trialsNCT07369505 2026-01-27
Sapu003 in Advanced mTOR-sensitive Solid Tumors
SAPU NANO (US) LLC
Phase 1 Recruiting
NCT07348211 2026-01-23
SIM0610-101
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT06558227 2024-12-16
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2 Recruiting
NCT04676633 2024-03-19
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Sirnaomics
Phase 1 Completed
NCT06124001 2023-11-15
Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma
CNBG-Virogin Biotech (Shanghai) Ltd.
Phase 1/2 Not yet recruiting
NCT03516448 2018-05-04
Expanding Phase III Study of Tyroserleutide for Injection
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT00034333 2005-06-24
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer
FeRx
Phase 2/3 Terminated
NCT00054951 2005-06-24
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
FeRx
Phase 1/2 Unknown